Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rentzos

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Immunology Letters|July 28, 2004
Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseasesMaria Michalopoulou, Chryssoula Nikolaou, Antonios Tavernarakis, et al.
Immunology Letters|March 28, 2006
Reply to "The role of soluble interleukin-6 receptor in inflammatory diseases" [Immunol Lett 2005;98(1):171]Maria Michalopoulou, Chryssoula Nikolaou, Stylianos Chatzipanagiotou, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 11, 2007
Circulating interleukin-15 in dementia disordersMichael Rentzos, George P Paraskevas, Elisabeth Kapaki, et al.
Journal of the Neurological Sciences|July 18, 2006
Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementiaMichael Rentzos, George P Paraskevas, Elisabeth Kapaki, et al.
Clinical Neurology and Neurosurgery|July 28, 2009
Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease durationElisabeth Andreadou, Chryssoula Nikolaou, Filippos Gournaras, et al.
Parkinsonism & Related Disorders|December 7, 2007
Folate and vitamin B12 levels in levodopa-treated Parkinson's disease patients: their relationship to clinical manifestations, mood and cognitionNikolaos I Triantafyllou, Chrysoula Nikolaou, Fotini Boufidou, et al.
Dementia and Geriatric Cognitive Disorders|August 30, 2017
Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum DisordersMara Bourbouli, Michael Rentzos, Anastasia Bougea, et al.
Neurological Research|August 26, 2009
Circulating interleukin-15 and RANTES chemokine in MS patients: effect of treatment with methylprednisolone in patients with relapseMichael Rentzos, Chryssoula Nikolaou, Antonis Rombos, et al.
Clinical Neurology and Neurosurgery|July 29, 2008
Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapseMichael Rentzos, Chryssoula Nikolaou, Antonis Rombos, et al.
European Neurology|April 22, 2010
Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosisMichael Rentzos, Antonis Rombos, Chryssoula Nikolaou, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Immunology Letters|July 28, 2004
Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseasesMaria Michalopoulou, Chryssoula Nikolaou, Antonios Tavernarakis, et al.
Immunology Letters|March 28, 2006
Reply to "The role of soluble interleukin-6 receptor in inflammatory diseases" [Immunol Lett 2005;98(1):171]Maria Michalopoulou, Chryssoula Nikolaou, Stylianos Chatzipanagiotou, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 11, 2007
Circulating interleukin-15 in dementia disordersMichael Rentzos, George P Paraskevas, Elisabeth Kapaki, et al.
Journal of the Neurological Sciences|July 18, 2006
Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementiaMichael Rentzos, George P Paraskevas, Elisabeth Kapaki, et al.
Clinical Neurology and Neurosurgery|July 28, 2009
Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease durationElisabeth Andreadou, Chryssoula Nikolaou, Filippos Gournaras, et al.
Parkinsonism & Related Disorders|December 7, 2007
Folate and vitamin B12 levels in levodopa-treated Parkinson's disease patients: their relationship to clinical manifestations, mood and cognitionNikolaos I Triantafyllou, Chrysoula Nikolaou, Fotini Boufidou, et al.
Dementia and Geriatric Cognitive Disorders|August 30, 2017
Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum DisordersMara Bourbouli, Michael Rentzos, Anastasia Bougea, et al.
Neurological Research|August 26, 2009
Circulating interleukin-15 and RANTES chemokine in MS patients: effect of treatment with methylprednisolone in patients with relapseMichael Rentzos, Chryssoula Nikolaou, Antonis Rombos, et al.
Clinical Neurology and Neurosurgery|July 29, 2008
Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapseMichael Rentzos, Chryssoula Nikolaou, Antonis Rombos, et al.
European Neurology|April 22, 2010
Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosisMichael Rentzos, Antonis Rombos, Chryssoula Nikolaou, et al.
Pageof 4